LJP 394 (Abetimus Sodium)

Abetimus Sodium · La Jolla Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LJP 394 (Abetimus Sodium), covering 2006-09-25 to 2015-09-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of LJP 394 (Abetimus Sodium) in Lupus Patients [Phase 2]